Results obtained with piracetam in foetal distress during labour. 1983

E J Huaman, and R Hassoun, and C M Itahashi, and G J Pereda, and M A Mejia

A double-blind study was performed on ninety-six parturients of the Lima Maternity Hospital, Peru, with some evidence of foetal distress who were given indistinguishably piracetam or a placebo at random in order to investigate the effects of the drug on the foetus. The conditions of the new-born babies who had received piracetam were superior to those of the babies treated with the placebo, as evaluated with the Apgar at 1, 5 and 10 minutes after birth and on the basis of the neurological and clinical examination as from 24 hours until they were released. In addition, the reduction of the duration of the labour in the patients treated with piracetam as compared with the control group was obvious.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007744 Obstetric Labor Complications Medical problems associated with OBSTETRIC LABOR, such as BREECH PRESENTATION; PREMATURE OBSTETRIC LABOR; HEMORRHAGE; or others. These complications can affect the well-being of the mother, the FETUS, or both. Complications, Labor,Labor Complications,Complication, Labor,Complication, Obstetric Labor,Complications, Obstetric Labor,Labor Complication,Labor Complication, Obstetric,Labor Complications, Obstetric,Obstetric Labor Complication
D010889 Piracetam A compound suggested to be both a nootropic and a neuroprotective agent. 2-Pyrrolidone-N-Acetamide,Avigilen,Axonyl,Cerebroforte,Cerepar N,Ciclofalina,Cuxabrain,Dinagen,Gabacet,Geram,Memo-Puren,Nootrop,Nootropil,Nootropyl,Normabraïn,Piracebral,Piracetam AbZ,Piracetam-RPh,Piracetrop,Pirazetam,Pyracetam,Pyramem,Sinapsan,UCB-6215,Memo Puren,Piracetam RPh,UCB 6215,UCB6215
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011760 Pyrrolidinones A group of compounds that are derivatives of oxo-pyrrolidines. A member of this group is 2-oxo pyrrolidine, which is an intermediate in the manufacture of polyvinylpyrrolidone. (From Merck Index, 11th ed) Pyrrolidinone,Pyrrolidone,Pyrrolidones
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001724 Birth Weight The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms. Birthweight,Birth Weights,Birthweights,Weight, Birth,Weights, Birth
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females

Related Publications

E J Huaman, and R Hassoun, and C M Itahashi, and G J Pereda, and M A Mejia
December 1969, Nursing times,
E J Huaman, and R Hassoun, and C M Itahashi, and G J Pereda, and M A Mejia
February 1969, Biomedical engineering,
E J Huaman, and R Hassoun, and C M Itahashi, and G J Pereda, and M A Mejia
February 1962, The Medical journal of Australia,
E J Huaman, and R Hassoun, and C M Itahashi, and G J Pereda, and M A Mejia
January 2000, The Cochrane database of systematic reviews,
E J Huaman, and R Hassoun, and C M Itahashi, and G J Pereda, and M A Mejia
June 2012, The Cochrane database of systematic reviews,
E J Huaman, and R Hassoun, and C M Itahashi, and G J Pereda, and M A Mejia
January 2002, The Cochrane database of systematic reviews,
E J Huaman, and R Hassoun, and C M Itahashi, and G J Pereda, and M A Mejia
June 1971, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
E J Huaman, and R Hassoun, and C M Itahashi, and G J Pereda, and M A Mejia
January 1964, Acta obstetricia et gynecologica Scandinavica,
E J Huaman, and R Hassoun, and C M Itahashi, and G J Pereda, and M A Mejia
January 1967, The Journal of the College of General Practitioners,
E J Huaman, and R Hassoun, and C M Itahashi, and G J Pereda, and M A Mejia
June 1953, Archives of disease in childhood,
Copied contents to your clipboard!